Login / Signup

Potential Application of Vaporized Drugs via Nasal Inhalers to Prevent Mortality and Central Nervous System Damage Caused by Primary Amoebic Meningoencephalitis Due to Naegleria fowleri.

Ruqaiyyah SiddiquiMohamed Yehia AbouleishMustafa KhamisTaleb IbrahimNaveed Ahmad Khan
Published in: ACS pharmacology & translational science (2021)
Here, it is proposed that nasal inhalers with specific anti-Naegleria fowleri drugs or a combination of anti-N. fowleri compounds combined with steroids such as dexamethasone could provide a practical solution for treating primary amoebic meningoencephalitis.
Keyphrases
  • low dose
  • cardiovascular events
  • high dose
  • type diabetes
  • coronary artery disease
  • cerebrospinal fluid
  • cardiovascular disease
  • drug induced
  • risk assessment
  • climate change